FDA allows diabetes drug Avandia to remain on the market with restrictions

ST LOUIS (MD Consult) - On September 23, 2010, the US Food and Drug Administration (FDA) announced that it has reached a decision about the continued marketing of the diabetes drug Avandia (rosiglitazone). Avandia is indicated for use by patients with type 2 diabetes whose glycemic control has been inadequate using other diabetes medications. The drug has recently been the subject of intense